Document Detail


The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy.
MedLine Citation:
PMID:  17437747     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this study was to evaluate the prognostic value of Doppler echocardiographically derived coronary flow reserve (CFR) in assessing inotropic response in patients with idiopathic dilated cardiomyopathy (IDC). One hundred thirty-two patients with IDC (90 men; mean age 62 +/- 11 years) were evaluated by transthoracic dipyridamole (0.84 mg/kg in 10 minutes) stress echocardiography. All patients had ejection fractions <40% (mean 33 +/- 7%) and angiographically normal coronary arteries, with New York Heart Association class <or=III. CFR was assessed in the left anterior descending coronary artery by pulsed Doppler as the ratio of maximal peak vasodilation (dipyridamole) to rest diastolic flow velocity. Inotropic reserve was identified as rest-stress variation in wall motion score index >0.25. All patients were followed for a median of 24 months. Mean CFR was 2.0 +/- 0.5. On individual patient analysis, 48 patients had normal CFR (>2), and 84 had abnormal CFR. The mean wall motion score index at rest was 2.0 +/- 0.33 and decreased to 1.8 +/- 0.4 at peak dipyridamole dose (p <0.000). Forty-two patients (32%) had inotropic reserve. During follow-up, 19 patients died, and 34 showed worsening of New York Heart Association class. The worst outcomes were observed in those patients with abnormal CFR and no inotropic reserve with high-dose dipyridamole. In a Cox model, mitral insufficiency (hazard ratio [HR] 1.7, 95% confidence interval [CI] 1.1 to 2.8), New York Heart Association class (HR 2.0, 95% CI 1.1 to 3.7), abnormal CFR (HR 2.8, 95% CI 1.0 to 8.5), wall motion score index at rest (HR 3.5, 95% CI 1.3 to 9.8), and the absence of inotropic reserve with high-dose dipyridamole (HR 2.3, 95% CI 1.06 to 5.1) were independent predictors of survival. In conclusion, in patients with IDC, CFR is often impaired. Reduced CFR and the absence of an inotropic response during vasodilator stress are additive in predicting a worse prognosis.
Authors:
Fausto Rigo; Sonia Gherardi; Maurizio Galderisi; Rosa Sicari; Eugenio Picano
Related Documents :
12452307 - Severe mitral regurgitation may prevent mural thrombus formation within the left ventri...
3843407 - Factor analysis in left ventricular first-pass radionuclide angiography: value of the v...
3995517 - Global and segmental left ventricular function in beta-thalassemia.
17543747 - The systolic to diastolic duration ratio in children with hypoplastic left heart syndro...
18227667 - Capnography and respiratory depression.
16837377 - Resting energy expenditure in injured, septic, and malnourished adult patients on intra...
Publication Detail:
Type:  Journal Article     Date:  2007-03-05
Journal Detail:
Title:  The American journal of cardiology     Volume:  99     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-17     Completed Date:  2007-06-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1154-8     Citation Subset:  AIM; IM    
Affiliation:
Cardiology Division, Umberto I Hospital, Mestre-Venice, Cesena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Flow Velocity / drug effects,  physiology
Bundle-Branch Block / physiopathology
Cardiac Output, Low / physiopathology
Cardiomyopathy, Dilated / physiopathology*,  ultrasonography
Coronary Angiography
Coronary Circulation / drug effects,  physiology*
Dipyridamole / diagnostic use*
Echocardiography, Doppler, Pulsed
Echocardiography, Stress*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Mitral Valve Insufficiency / physiopathology
Myocardial Contraction / drug effects,  physiology*
Prognosis
Prospective Studies
Stroke Volume / drug effects,  physiology
Survival Rate
Vasodilator Agents / diagnostic use*
Ventricular Function / drug effects,  physiology
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ventricular arrhythmias during left ventricular assist device support.
Next Document:  Sinus of Valsalva aneurysms--47 years of a single center experience and systematic overview of publi...